Related Links
Alpha-1 as Seen
on PBS
Watch the PBS show about Alpha-1.
ARALAST NP Therapy
Choose a therapy that offers you the support you need.
Alpha-1 Kits and Brochures
ARALAST NP Patient
Education Kit
The updated ARALAST NP Patient Education Kit is your resource for living with AAT deficiency*. Baxter is pleased to provide this helpful packet of information and resources, designed for Alpha-1 patients and their families.
*Also known as Alpha-1, alpha-1 antitrypsin deficiency, AATD, A1-PI deficiency, alpha-1 proteinase deficiency, A1AD, or hereditary or genetic emphysema.
In the kit, you will find these booklets and tools:
- Take a Closer Look Booklet—Learn about genetics, testing, diagnosis, augmentation therapy, and healthy living for AAT deficiency.
- ARALAST NP AATmosphere Program Booklet—See how this program surrounds you with Alpha-1 support, including Insurance Assistance, One-on-One Support, Knowledge Network, and Alpha-1 Security.
- ARALAST NP AATmosphere Program Enrollment Form—Now it’s easy for you to start enjoying the benefits of this helpful program.
- Music for Relaxation CD—Take some time for yourself and relax with this selection of soothing woodwind arrangements.
You may order a Patient Education Kit online or by phone at 1-866-ARALAST (272-5278).
Take a Closer Look Patient Booklet
Wherever you are in your journey with AAT deficiency, you will find helpful information in this booklet.
Topics include:
- Understanding AATD
- How AATD affects you and your family
- Genetics of AATD
- GINA and how it protects you
- Testing for AATD
- How to live better with AATD
- Augmentation therapy with ARALAST NP therapy
- Support programs from ARALAST NP AATmosphere program
- Glossary of Alpha-1 words
You may order the Patient Booklet online or by phone at 1-866-ARALAST (272-5278).
You may also download a copy of the booklet.
ARALAST NP [Alpha1-Proteinase Inhibitor (Human)]
ARALAST NP is indicated for chronic augmentation therapy in patients having congenital deficiency of A1-PI with clinically evident emphysema. ARALAST NP is not indicated as therapy for lung disease patients in whom congenital A1-PI deficiency has not been established.
The effect of augmentation therapy with ARALAST NP on pulmonary exacerbations and on the progression of emphysema in alpha1-antitrypsin deficiency has not been demonstrated in randomized, controlled clinical trials.
Please review the Important Risk Information and the Full Prescribing Information
Please review the Important Risk Information and the Full Prescribing Information
